Aktuelle Geschäftsvorschläge - Österreich und international

Sehen Sie sich Investitionsmöglichkeiten im Bereich Medizin und Pharma an. Sehen Sie sich Projekte von Startups und Unternehmern bis hin zu etablierten Firmen und globalen Marken an, die alle auf der Suche nach Angel-Investoren in Österreich und auf der ganzen Welt via Österreichisches Investment Netz sind.

28 investments found

Display by
Medikamentenentwicklung

Medikamentenentwicklung

location_onWien, Österreich

Entwicklung eines breit wirksamen antiviralen Medikaments. Sensationeller Durchbruch bei der Bekämpfung von Viren! Medikamenten-Umsatz weltweit 53 Mdn $, diese bekämpfen nur einzelne Stämme. Viraus-Spray wirkt auf Covid, Sars, RSV, Influenza...

  • exklusives anti-virales Medikament mit Breitenwirkung
  • Wortmarke "Viraus" angemeldet und internat. absicherbar
  • alle Experimente und Studien beweisen die breite Wirkung

€ 900.000

Total Required

€ 90.000

Min per Investor
BBKItty:  Baby Comfort

BBKItty: Baby Comfort

location_onLuzon, Philippinen

BB Kitty is the first diaper brand in the Philippines to sell per piece; We cater to Filipinos’ “try first” buying behavior and affordability concerns. Our eCommerce & retail strategy makes premium diapers accessible to all.

  • First diaper brand selling per piece in the Philippines.
  • Massive demand – ₱58B market with 1.85M+ births yearly.
  • Affordable premium brand disrupting a bulk-pack industry.

€ 150.000

Total Required

€ 2.000

Min per Investor
Pet Track & Retrieve

Pet Track & Retrieve

location_onGreater London, Großbritannien

Implantable GPS & health chip + mobile app for real-time pet tracking, escape alerts & peace of mind. Built for safety, driven by love.”

  • Implantable GPS + health chip for real-time pet tracking
  • Trademark filed and IP protection underway
  • Inclusive pricing—discounts for pensioners & low-income homes

€ 125.000

Total Required

€ 3.000

Min per Investor
Healthcare Automated

Healthcare Automated

location_onAlberta, Kanada

● Wosler is a Healthcare Technology company working to improve access to healthcare regardless of labor availability. Our current solution allows hospitals and clinics to access healthcare labour 10x quicker and more affordably.

  • Human Testing Success: We recently conducted multiple successful live test
  • Commercial Traction: We're seeing early traction, with pre-sales commitment
  • Growing revenue, currently $300K/month

€ 1.300.000

Total Required

€ 35.000

Min per Investor
Bioimport S.A.C.

Bioimport S.A.C.

location_onPeru, Peru

Negocio: Importar y vender en el país de Perú insumos médicos para hemodiálisis. Productos: Kit de hemodiálisis compuesto por dializador, líneas de sangre y agujas fistula.

  • Nuestra ventaja competitiva: • Bajo costos operativos
  • • Excelente calidad de productos. • Precio bajo de compra en R.P. China
  • • Nuestro gerente y personal de ventas tiene más de 10 años de experiencia

€ 750.000

Total Required

€ 25.000

Min per Investor
Nurish Pro

Nurish Pro

location_onDublin, Irland

Nurish Pro is building AI platform that makes nutritional and dietetic care easier than ever before for everyone: enabling more successful outcomes, providing a better customer experience, and building a stronger business for dietitians.

  • Solves key dietitian pain by providing new AI technology
  • Working AI prototype ready | Website is LIVE and running
  • Since launch last month, 5 Customers signed up on the free trial version

€ 500.000

Total Required

€ 5.000

Min per Investor
Last raise before exit

Last raise before exit

location_onNordwest, Schweiz

Preci Health SA is transforming blood collection with its ezdraw™ device, enabling painless sampling in clinics, pharmacies, and at-home sampling, raising CHF 15M ($18M) series B to scale manufacturing, trials, approvals, for an exit by 1Q 2026.

  • Targeting a very significant market $80.85B in 2024 -157.56B by 2034
  • Finished product and 4 strategic investors
  • Leading and global Labs and IVD player as partners

€ 11.000.000

Total Required

€ 25.000

Min per Investor
Dote Pitch Deck

Dote Pitch Deck

location_onNordwest, Großbritannien

Dote is reinventing the parenting experience through its technology and products.

  • Great enthusiasm from major retailers incl Target with est $7-9M Revenue Y1
  • Signed contract with amazon estimating $4.5M revenue in Y1
  • Completed tooling, regulatory, branding, prototypes. Ready for production

€ 3.600.000

Total Required

€ 25.000

Min per Investor
The Care Company

The Care Company

location_onSingapur, Singapur

Service Provider of Retirement & Nursing Care with a focus on: 1. Addressing the idleness & an abundance of free time of clients, 2. Decentralised decision-making in the workforce supported by AI tools & data, and 3. Sustainability in operations.

  • Meaningful programs for genuine engagement, sense of autonomy & competency.
  • Environment that promotes healthy mental state for both clients & workforce
  • Decentralized decision-making to create a sense of responsibility in staff.

€ 700.000

Total Required

€ 35.000

Min per Investor
Enertor Insoles

Enertor Insoles

location_onEast Anglia, Großbritannien

Transform sports recovery & performance with Enertor's PX1® insoles—revolutionary technology reducing impact by 51%. Endorsed by Usain Bolt, we aim to be the next £1B brand. Invest in innovation redefining running and injury prevention. Raised £330K✅

  • 69% injury reduction proven in clinical trials with British Army
  • Endorsed by Usain Bolt; trusted by elite athletes worldwide
  • Rated best insoles by The New York Times and Runner's World

€ 350.000

Total Required

€ 6.000

Min per Investor
RT MicroDx

RT MicroDx

location_onNordosten, Vereinigte Staaten von Amerika

RT MicroDx is revolutionizing home diagnostics with an affordable, rapid-testing platform. Our solution enables lab-accurate results in minutes, addressing a $64B market. Backed by SBIR funding, we seek angels to fuel growth & commercialization

  • We have a working prototype
  • We have interest from major players in the space including Roche Diagnostic
  • Co-founding team includes biggest name in public health space

€ 1.900.000

Total Required

€ 25.000

Min per Investor
Ortus-iHealth

Ortus-iHealth

location_onGreater London, Großbritannien

Ortus offers advanced cardiovascular care solutions that enhance patient management and clinical efficiency. Our remote monitoring platform provides real-time insights, enabling clinicians to make quick, data-driven decisions for better outcomes.

  • Tripled 2024 revenue to £650,000, on track to double it again in 2025
  • 3-year contract with London Cardiac Network: access to over 1.2mm patients
  • Five-year partnership with the University of Colorado Anschutz Medical Camp

€ 1.800.000

Total Required

€ 10.000

Min per Investor
Yma - SLM Powered Medtech

Yma - SLM Powered Medtech

location_onVereinigte Arabische Emirate, Vereinigte Arabische Emirate

Yma (www.yma.health) develops AI agents covering diagnostics, prevention, adherence and therapy for trillion-dollar chronic conditions enabling personal, personable, private and holistic health-span services. Already raised $2.5M Website is LIVE.

  • Small Language Model encoding chronic conditions for prevention & adherence
  • Built by a veteran global team with data-heavy medtech exits
  • Validated in the GCC region and cost-competitive for healthcare industry

€ 4.800.000

Total Required

€ 250.000

Min per Investor
Test pitch AU test 34thtrgfdsadf

Test pitch AU test 34thtrgfdsadf

location_onNew South Wales, Australien

test 23456

  • 234
  • 566
  • 6566

€ 5.400.000

Total Required

€ 600

Min per Investor
Vet Link

Vet Link

location_onVereinigte Arabische Emirate, Vereinigte Arabische Emirate

Vet Link is a cutting-edge, first-of-its-kind smart veterinary clinic that sets itself apart as a unique referral clinic in the world, utilizing the most advanced AI technologies and teleconsultation systems.

  • First of its kind worldwide
  • Targets a $81–90M valuation by Year 5
  • Strategic Partnerships with Clinics, Not Competition

€ 9.500.000

Total Required

€ 475.000

Min per Investor
Quimica Vakmes S.A. DE CV

Quimica Vakmes S.A. DE CV

location_onMexiko, Mexiko

Distribuidora especializada en productos químicos, equipos e insumos premium para laboratorios médicos, farmacéuticos e industriales. Busca capital para expandir inventario estratégico ante demanda creciente de clientes líderes en México.

  • Distribuidor especializado con presencia en sectores salud e industria.
  • Amplia base de clientes líderes y diversificados.
  • Crecimiento sostenido y resultados comprobados.

€ 950.000

Total Required

€ 25.000

Min per Investor
Disruptive Supplement

Disruptive Supplement

location_onSingapur, Singapur

Discovery of a compound from a natural extract that can treat muscle soreness that will become the next BCAA or creatine, except this time it'll work definitively.

  • Market entry of a supplement that will change the human condition
  • Novel uses of it to disrupt the fitness nutrition world
  • Higher training volumes, shorter rest periods, etc.

€ 1.400.000

Total Required

€ 15.000

Min per Investor
Healthcare Facility

Healthcare Facility

location_onSingapur, Singapur

We are a healthcare organisation based in Singapore comprising dental & medical facilities. Founded in 2017 it has expanded to strategically located dental clinics and a medical & allied health facility. The group is already profitable. Huge market

  • Founded in 2017 and profitable
  • Very good reputation among patients
  • Have our own in house advertising, marketing, finance, HR, operations

€ 1.400.000

Total Required

€ 350.000

Min per Investor
ōmPoint:  Wellness App

ōmPoint: Wellness App

location_onSüdosten, Vereinigte Staaten von Amerika

ōmPoint is a next-gen wellness app combining AI with mental well-being. Revenue set to grow from ~$0.35M (2025) to ~$227M (2029), with gross margins rising from ~57% to ~70% by 2027. A timely solution—your personal resilience coach, always at hand.

  • Elite athlete validation – Proven impact on high-performance users
  • Strong retention – 87% D1, 70% D30, showing long-term user value
  • Profitable growth – CAC <$60, 2x ROAS, ARPU >$20, LTV >$120

€ 1.900.000

Total Required

€ 25.000

Min per Investor
MediTrust- Guinea Bissau

MediTrust- Guinea Bissau

location_onNordwest, Großbritannien

Currently, people of Guinea Bissau(W. Africa) have to travel to Senegal/Portugal for their basic healthcare needs- Diagnostic Radiology, MRI, CT, Angiograph,y etc. MediTrust is committed to delivering the above services locally to eliminate foreign travel.

  • Services we are providing are not available in the entire country
  • We have service agreement with INSS with committed 30,000 patients base
  • We have existing facility with all local support staff including nurses

€ 350.000

Total Required

€ 125.000

Min per Investor
Firstday Healthcare SAFE

Firstday Healthcare SAFE

location_onSüdosten, Vereinigte Staaten von Amerika

Firstday Healthcare is a Children's Hospital at-home platform built off the success of the adult care model but built for the needs of the pediatric and newborn population

  • Built by Neonatologists and made for parents
  • Product in use with leading hospitals
  • About to execute a 1m Medicaid contract to provide NICU at Home

€ 550.000

Total Required

€ 25.000

Min per Investor
Bloodsaver

Bloodsaver

location_onNordwest, Schweiz

Patented medical innovation designed to virtually eliminate blood loss during surgery. This innovation sets a new standard for surgical safety and patient care.

  • Patent valuation (Top 50): CHF 429M (license analogy method)
  • Feasibility study successfully completed
  • A detailed, realistic development plan up to certification is in place

€ 3.200.000

Total Required

€ 275.000

Min per Investor
Logensa for Healthcare

Logensa for Healthcare

location_onBaden-Württemberg, Deutschland

Logensa is a scalable SaaS solution tailored for the healthcare sector in Germany. We streamline and digitalize administrative workflows and are currently seeking investors to support product completion and market entry by mid-2025.

  • Essential modules such as task management and calendar have been completed.
  • Customer portal with automated billing has been completed.
  • The design of the entire application has been completed.

€ 1.500.000

Total Required

€ 300.000

Min per Investor
Cam AI: Teen Lifeline

Cam AI: Teen Lifeline

location_onEast Anglia, Großbritannien

A Cambridge Uni spinout developing a foundational AI model built on real psychology data for an always-on conversational AI. We are psychology experts using technology to support adolescents using Psychological First Aid rather than Psychotherapy.

  • Experienced team including ex-Meta CEO
  • £750,000 already raised and implemented
  • SEIS and EIS available now

€ 4.200.000

Total Required

€ 1.000

Min per Investor
HealthTech AI/ML B2B SaaS

HealthTech AI/ML B2B SaaS

location_onNordosten, Vereinigte Staaten von Amerika

Ursamin is transforming care coordination with AI-powered tools that reduce admin burden for clinicians and unlock patient insights. We help doctors do what they do best—care—while health systems gain efficiency and better data-driven decisions

  • AI-powered platform reduces admin burden and scales care coordination.
  • Pilots show real ROI—40% less admin, $500K+ in added annual revenue.
  • Interoperable from day one—live in weeks, not years, across systems.

€ 475.000

Total Required

€ 25.000

Min per Investor
Imbue Healthcare

Imbue Healthcare

location_onGauteng, Südafrika

Missing Medicine: South Africa is often overlooked for medicine launches as big pharma prioritizes larger markets, despite these drugs being commercially successful elsewhere. Medicines worth $300 million never make it to South Africa

  • Average Annual Turnover per Product: $1-2 million
  • Gross Margin: 70%
  • Time to Registration: 1-2 Years

€ 475.000

Total Required

€ 25.000

Min per Investor
Entac Medical Inc.

Entac Medical Inc.

location_onSüdosten, Vereinigte Staaten von Amerika

Entac develops AI-driven acoustic wearables predicting patient adverse events, with its first launched device, PrevisEA, targeting an $8 billion market and a pipeline for multiple high-value healthcare sectors exceeding $20 billion.

  • PrevisEA Commitments: 2 hospitals systems (63 hospitals) $21M revenue oppy
  • In review: 7 systems (74 hospitals) - $41M opportunity. Commitment due
  • Engaged: 5 systems (66 hospitals) - $46M opportunity - Expected in 2025.

€ 1.900.000

Total Required

€ 50.000

Min per Investor
Featured test

Featured test

location_onHongkong, Hong Kong

dfsfsg

  • gsgsg
  • sgs
  • gsgs

€ 125.000

Total Required

€ 0

Min per Investor
Per Page 36
Loading…
Loading the web debug toolbar…
Attempt #